Tohoku University Graduate School of Medicine, Sendai, Japan.
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211048706. doi: 10.1177/15330338211048706.
Dosimetric parameters of the planning target volume (PTV) and organs at risk (OARs) were compared among 3 different radiotherapy (RT) modalities in left breast cancer patients after breast-conserving surgery (BCS). Eleven patients with left breast cancer after BCS were enrolled and underwent CT simulation in the free breathing (FB) and deep inspiration breath-hold (DIBH) position. Three-dimensional conformal RT (3DCRT) and volumetric modulated arc therapy (VMAT) plans were generated for each patient in the DIBH positions. A 3DCRT plan was also created in the FB position. A dose-volume histogram (DVH) was used to analyze each evaluation index of PTV and OARs. The principal outcomes were PTV dose, heart dose, right breast dose, left anterior descending coronary artery (LADCA) dose, and left lung dose. For 3DCRT plans, significant dose reductions were demonstrated in all evaluation parameters of the heart, LADCA, and left lung doses in the DIBH position compared with those in the FB position ( < 0.05). In the DIBH position, significant dose reductions were found in the heart and LADCA in VMAT plans compared to those in 3DCRT plans ( < 0.05). For the right breast, VMAT reduced Dmean significantly (0.32 Gy vs 0.08 Gy, < 0.01). There were no significant differences between 3DCRT and VMAT plans for the left lung dose in the DIBH position. The indicators of PTV had no significant difference between the 3 plans. DIBH and VMAT could reduce dosimetric parameters of the OARs in left breast cancer patients after BCS. RT plans for left breast cancer after BCS can be optimized by DIBH and VMAT techniques to minimize radiation-induced toxicity.
在接受保乳手术后(BCS)的左乳腺癌患者中,比较了 3 种不同放射治疗(RT)方式的计划靶区(PTV)和危及器官(OAR)的剂量学参数。
入组 11 例接受 BCS 后的左乳腺癌患者,在自由呼吸(FB)和深吸气屏气(DIBH)位置进行 CT 模拟。为每位患者在 DIBH 位置生成三维适形 RT(3DCRT)和容积调制弧形治疗(VMAT)计划。还在 FB 位置创建了 3DCRT 计划。使用剂量体积直方图(DVH)分析 PTV 和 OAR 的每个评估指标。主要结局是 PTV 剂量、心脏剂量、右侧乳房剂量、左前降支冠状动脉(LADCA)剂量和左肺剂量。
对于 3DCRT 计划,与 FB 位置相比,DIBH 位置的所有心脏、LADCA 和左肺剂量评估参数均显示出显著的剂量降低( < 0.05)。在 DIBH 位置,与 3DCRT 计划相比,VMAT 计划在心脏和 LADCA 中的剂量降低更为显著( < 0.05)。对于右侧乳房,VMAT 显著降低 Dmean(0.32 Gy 比 0.08 Gy, < 0.01)。在 DIBH 位置,3DCRT 和 VMAT 计划之间的左肺剂量无显著差异。3 种计划的 PTV 指标无显著差异。
DIBH 和 VMAT 可降低接受 BCS 的左乳腺癌患者 OAR 的剂量学参数。可以通过 DIBH 和 VMAT 技术优化接受 BCS 的左乳腺癌的 RT 计划,以最大程度地减少放射性毒性。